标准化治疗方案治疗MDR-TB 26例近期疗效分析  

Short-term curative effect of standardized treatment project for 20 cases of MDR-TB

作　　者：邱跃灵[1] 殷建团[1] 黄申晖 

机构地区：[1]解放军第175医院呼吸结核科(厦门大学附属东南医院),福建漳州363000

出　　处：《临床肺科杂志》2015年第11期1972-1974,共3页Journal of Clinical Pulmonary Medicine

摘　　要：目的评价全球基金结核病项目标准化耐多药肺结核治疗方案对耐多药肺结核(MDR-TB)的疗效。方法观察26例MDR-TB采用标准化耐多药肺结核治疗方案后1个月、6月、12月的痰菌计数、病灶吸收、体重指数变化。结果在治疗后6个月,痰菌计数、病灶吸收、体重指数均较前改善,统计有差异性(P<0.05)。结论全球基金结核病项目标准化耐多药肺结核治疗方案对MDR-TB的近期疗效好,值得进一步临床观察及病例积累。Objective To evaluate the therapeutic effect of global fund TB project standardization of MDR-TB treatment on MDR-TB patients. Methods 26 cases of MDR-TB were given Global fund TB project standardiza-tion of MDR-TB treatment. Their sputum bacteria count, focal absorption and BMI were observed 1, 6 and 12 months after the treatment. Results 6 months after the treatment, their sputum bacteria count, focal absorption and BMI improved significantly （ P〈0. 05 ） . Conclusion Global fund TB project standardization of MDR-TB treatment has good short-term curative effect, which is worthy of further clinical observation.

关 键 词：全球基金结核病项目 标准化耐多药肺结核治疗方案 耐多药肺结核 近期疗效 

分 类 号：R521[医药卫生—内科学]